At the beginning of November, we were delighted to hear the news that we finally had a vaccine against Covid-19. It has a high success rate in combating the disease and with an approximate date for vaccination to begin.
Finally, after so many months of suffering and uncertainty, since the beginning of November we had approximate date for vaccination against Covid-19. First, the American pharmaceutical Pfizer together with his German partner BionTech, were taking the lead to find a vaccine. Your vaccine has a 90% effective and consists of two doses of the drug. The company has announced that they have already made license applications for the drug and are waiting for it. In addition, they have also communicated that they expect supply 50 million doses before the end of this year, and 1.300 billion for next year.
A week later, the American pharmacist Modern announced that his vaccine was also ready and that he had a 94,5% Effectivenessbased on provisional data from your clinical trial. In this way, it became the second American company to confirm results that would far exceed expectations.
In the race are other laboratories who also have their project in phase 3, with thousands of people involved in the trial. According to the WHO registry, they stand out another ten prototypes in advanced stage, being the British vaccine of Oxford y AstraZeneca. They follow him A nephew (CH), WUHAN Institute of Biological Products (CH); Synopharm (CH); Beijing Institute of Biological Products (CH); CanSino Biological (CH); Gamaleya Research Institute (RUS); Janssen (USA); novavax (USA).
In so far this year the first impact news that we met was the project of Oxford / Astrazeneca. In October the company announced that by November they expected to have the vaccine with a similar immunity in young and old.
On the other hand, the American company novavax it also announced last month that it had obtained clearance and approval for its vaccine. Your candidate is also in phase 3, and already orGet the “Fast Track” award by FDA, Food and Drug Administration. This them accelerates the development of your drug. However, several companies have had that concession for a few weeks, Pfizer obtained it in July for example.
La European Commission has already signed definitive contracts with three companies: Johnson & Johnson 200 million doses; AstraZeneca 300 million and Sanofi-GSK 300 million. Of course with Pfizer and BioNTech as well, and they have conversations with Moderna and CureVac. All this in order to obtain a wide portfolio of vaccines to face the disease that has caused so much havoc in 2020.
The WHO has already set the middle of next year as the date for the vaccine to be ready for distribution. According to its chief scientist, Soumya Swaminthan, we must prevent the unpredictability of the date, as it is possible that we will get results in early 2021.
When will the vaccine arrive in Spain?
Salvador Illa, the Minister of Health, has assured that "If all goes well", the first doses will arrive at the end of this year. These doses to face the Covid-19 vaccine will be from the British pharmaceutical AstraZeneca. A double dose vaccine that is also in phase 3. So "at the end of December this year we could start having the first doses."
Are you looking for supplements and / or natural products that help strengthen your defenses? click and find the best products to prevent flu and colds this winter.
